SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-010536
Filing Date
2016-12-13
Accepted
2016-12-13 16:38:14
Documents
57
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20161031x10q.htm 10-Q 1729383
2 EX-31.1 bpmx_ex311.htm EX-31.1 19475
3 EX-31.2 bpmx_ex312.htm EX-31.2 19628
4 EX-32.1 bpmx_ex321.htm EX-32.1 11630
  Complete submission text file 0001558370-16-010536.txt   5836870

Data Files

Seq Description Document Type Size
5 EX-101.INS bpmx-20161031.xml EX-101.INS 1082462
6 EX-101.SCH bpmx-20161031.xsd EX-101.SCH 36787
7 EX-101.CAL bpmx-20161031_cal.xml EX-101.CAL 40940
8 EX-101.DEF bpmx-20161031_def.xml EX-101.DEF 193038
9 EX-101.LAB bpmx-20161031_lab.xml EX-101.LAB 339325
10 EX-101.PRE bpmx-20161031_pre.xml EX-101.PRE 316303
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 162049319
SIC: 2834 Pharmaceutical Preparations